Published in Women's Health Weekly, December 16th, 2004
"As circulating levels of vascular endothelial growth factor (VEGF-A) are raised in malignancy, the aim of this study was to investigate whether similar changes occur in two related factors, VEGF-D and the soluble VEGF-A receptor Flt-1 (sFlt-1). Circulating levels of VEGF-A, VEGF-D and sFlt-1 were determined by enzyme-linked immunosorbent assay (ELISA) in 51 patients with primary breast cancer and matched healthy controls. Results were correlated with clinicopathological data," investigators in England report.
"Whilst there was a difference in VEGF-A levels between patient...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly